# OnCo record nct05112991 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05112991/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05112991", "NCT05112991" ;
  schema:name "Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer"@en ;
  schema:description "A phase 2 trial of Envafolimab, Lenvatinib in endometrial cancer, run by 3D Medicines (Sichuan) Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05112991/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05112991> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-03-04" ;
  onco:cancers <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/advanced-recurrent-endometrial-cancer/> ;
  onco:technologies <https://onco.cc/technologies/antiangiogenic/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/envafolimab/>, <https://onco.cc/drugs/lenvatinib/> ;
  onco:companies <https://onco.cc/companies/3d-medicines/> .